Intravitreal (IVT) Injectable Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 March 11
SKU : PH1074
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
What is an intravitreal injection?
An intravitreal injection is a minimally invasive procedure where medication is injected directly into the vitreous cavity of the eye to treat various conditions.
What are the main factors driving the intravitreal injectable market?
The growing prevalence of chronic eye diseases like cataracts and macular degeneration is a key driver.
Which type of drug holds the largest share of the intravitreal injectable market?
Anti-VEGF drugs hold the dominant share due to their effectiveness in treating fluid leakage caused by eye disorders.
What is an example of an anti-VEGF drug used in intravitreal injections?
Ranibizumab (Lucentis) is an example of an anti-VEGF drug used to treat wet age-related macular degeneration.
Related Reports
healthcare-itClinical IT Systems Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 03
Starting from
$4350
materialsPrintable Self-Adhesive Vinyl Films Market Size, Share, Industry, Forecast and Outlook (2024-2031)
Published: 2024 January 30
Starting from
$4350
packagingInflatable Packaging Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 September 29
Starting from
$4350
medical-devicesLyophilized Injectable Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 February 08
Starting from
$4350
animal-health
Inflatable Pet Collar Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 October 26
Starting from
$4350
medical-devicesSterile Injectable Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 April 01
Starting from
$4350